Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 11, Issue 3, Pages 223
Publisher
MDPI AG
Online
2021-03-22
DOI
10.3390/jpm11030223
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice
- (2020) Hara Afaloniati et al. OncoTargets and Therapy
- A clinical trial with valproic acid and hydralazine in combination with gemcitabine and cisplatin followed by doxorubicin and dacarbazine for advanced hepatocellular carcinoma
- (2020) Yao‐Chung Liu et al. Asia-Pacific Journal of Clinical Oncology
- Valproic acid reverses Sorafenib resistance through inhibiting activated Notch/Akt signaling pathway in HCC
- (2020) Xu Yang et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Valproic acid overcomes sorafenib resistance by reducing the migration of Jagged2-mediated Notch1 signaling pathway in hepatocellular carcinoma cells
- (2020) Jing Liu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma
- (2019) Sarah W. Gordon et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
- (2019) Kim Freese et al. Cancers
- Sensitization to oxidative stress and G2/M cell cycle arrest by histone deacetylase inhibition in hepatocellular carcinoma cells
- (2019) Hae-Ahm Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence
- (2018) MARILITA M. MOSCHOS et al. ANTICANCER RESEARCH
- Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21Waf1/Cip1 and p19INK4d upregulation in hepatocellular carcinoma
- (2018) Hengyu Zhou et al. CELL PROLIFERATION
- Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
- (2018) Diana Llopiz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment
- (2018) Dimitrios Schizas et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells
- (2017) Subbroto Saha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma
- (2017) Alina Kutsenko et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
- (2017) Dimitrios Dimitroulis et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Resminostat induces changes in epithelial plasticity of hepatocellular carcinoma cells and sensitizes them to sorafenib-induced apoptosis
- (2017) Jitka Soukupova et al. Oncotarget
- Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression
- (2017) Jing Yang et al. Scientific Reports
- Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
- (2017) Jeong Il Yu et al. Scientific Reports
- Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Αgainst Medullary Thyroid Cancer?
- (2016) CHRISTOS DAMASKOS et al. ANTICANCER RESEARCH
- Activation of mPTP-dependent mitochondrial apoptosis pathway by a novel pan HDAC inhibitor resminostat in hepatocellular carcinoma cells
- (2016) Meili Fu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Population attributable fractions of risk factors for hepatocellular carcinoma in the United States
- (2016) Oxana V. Makarova-Rusher et al. CANCER
- Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics
- (2016) Faisal Saeed Khan et al. Hepatology International
- Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030
- (2016) Jessica L. Petrick et al. JOURNAL OF CLINICAL ONCOLOGY
- Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study
- (2016) Michael Bitzer et al. JOURNAL OF HEPATOLOGY
- NLRC5/MHC class I transactivator is a target for immune evasion in cancer
- (2016) Sayuri Yoshihama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Droxinostat, a Histone Deacetylase Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cell Lines via Activation of the Mitochondrial Pathway and Downregulation of FLIP
- (2016) Jing Liu et al. Translational Oncology
- Histone deacetylase (HDAC)-1, −2, −4 and −6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients’ survival
- (2015) Constantinos Giaginis et al. BMC GASTROENTEROLOGY
- Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
- (2015) Robert J. Wong et al. GASTROENTEROLOGY
- The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expression
- (2015) SUSANNE GAHR et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling
- (2015) Guangchun Sun et al. Journal of Cancer
- Histone Deacetylase Inhibitors and Colorectal Cancer: what is new?
- (2014) Athanasios Tampakis et al. Anti-Cancer Agents in Medicinal Chemistry
- A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma
- (2014) Francine Foss et al. BRITISH JOURNAL OF HAEMATOLOGY
- A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells
- (2014) Joan Fernando et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling
- (2014) FEI-TING HSU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours
- (2014) ELIENE BOGAERTS et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model
- (2014) P Yu et al. LEUKEMIA
- Inhibition of autophagy significantly enhances combination therapy with sorafenib and HDAC inhibitors for human hepatoma cells
- (2014) Hang Yuan WORLD JOURNAL OF GASTROENTEROLOGY
- Histone deacetylase inhibitors
- (2013) Marije Slingerland et al. ANTI-CANCER DRUGS
- Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II
- (2013) Cheguo Tsai et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis
- (2013) MITSUHIRO HISHIDA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Notch signaling and new therapeutic options in liver disease
- (2013) Carola Maria Morell et al. JOURNAL OF HEPATOLOGY
- Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines
- (2012) Steffen Zopf et al. BMC CANCER
- Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells
- (2012) Reena Buurman et al. GASTROENTEROLOGY
- Radiosensitizing Effect of a Phenylbutyrate-Derived Histone Deacetylase Inhibitor in Hepatocellular Carcinoma
- (2012) Yen-Shen Lu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
- (2012) Winnie Yeo et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib
- (2012) Anja Lachenmayer et al. JOURNAL OF HEPATOLOGY
- Non-Fatal and Fatal Liver Failure Associated with Valproic Acid
- (2012) M. Schmid et al. PHARMACOPSYCHIATRY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation
- (2011) Raquel Urtasun et al. HEPATOLOGY
- Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway
- (2011) Patrick Viatour et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hepatocellular Carcinoma Risk Factors and Disease Burden in a European Cohort: A Nested Case-Control Study
- (2011) D. Trichopoulos et al. JNCI-Journal of the National Cancer Institute
- Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer
- (2011) Mingquan Chen et al. PLoS One
- Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC
- (2011) Karl Quint et al. VIRCHOWS ARCHIV
- The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells
- (2010) Yun Dai et al. BRITISH JOURNAL OF HAEMATOLOGY
- The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells
- (2010) Sonja Mandl-Weber et al. BRITISH JOURNAL OF HAEMATOLOGY
- The clinical development of histone deacetylase inhibitors as targeted anticancer drugs
- (2010) Paul A Marks EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands
- (2010) T. E. Wood et al. MOLECULAR CANCER THERAPEUTICS
- Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma
- (2010) Li-Ming Wu et al. PLoS One
- Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
- (2009) S J Schoenleber et al. BRITISH JOURNAL OF CANCER
- Sorafenib
- (2009) Gillian M. Keating et al. DRUGS
- Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors
- (2009) H Miles Prince et al. Future Oncology
- Risk of HCC: Genetic heterogeneity and complex genetics
- (2009) Tommaso A. Dragani JOURNAL OF HEPATOLOGY
- Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis
- (2009) X Liu et al. ONCOGENE
- Racial and Ethnic Variations in Hepatocellular Carcinoma Incidence within the United States
- (2008) Robert Wong et al. AMERICAN JOURNAL OF MEDICINE
- Molecular therapy for the treatment of hepatocellular carcinoma
- (2008) T F Greten et al. BRITISH JOURNAL OF CANCER
- Valproic Acid Induces Notch1 Signaling in Small Cell Lung Cancer Cells
- (2008) Christopher S. Platta et al. JOURNAL OF SURGICAL RESEARCH
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started